Amalgamated Bank’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-9,554
| Closed | -$1.64M | – | 2201 |
|
|
2021
Q3 | $1.64M | Sell |
9,554
-581
| -6% | -$100K | 0.01% | 1017 |
|
|
2021
Q2 | $1.27M | Buy |
10,135
+762
| +8% | +$95.6K | 0.01% | 1167 |
|
|
2021
Q1 | $1.27M | Sell |
9,373
-788
| -8% | -$107K | 0.05% | 422 |
|
|
2020
Q4 | $1.3M | Hold |
10,161
| – | – | 0.05% | 398 |
|
|
2020
Q3 | $1.14M | Buy |
10,161
+871
| +9% | +$98K | 0.05% | 385 |
|
|
2020
Q2 | $885K | Buy |
9,290
+1,498
| +19% | +$143K | 0.04% | 475 |
|
|
2020
Q1 | $700K | Sell |
7,792
-199
| -2% | -$17.9K | 0.02% | 754 |
|
|
2019
Q4 | $424K | Buy |
7,991
+245
| +3% | +$13K | 0.01% | 1209 |
|
|
2019
Q3 | $306K | Sell |
7,746
-108
| -1% | -$4.27K | 0.01% | 1313 |
|
|
2019
Q2 | $323K | Buy |
7,854
+1,649
| +27% | +$67.8K | 0.01% | 1317 |
|
|
2019
Q1 | $289K | Buy |
6,205
+649
| +12% | +$30.2K | 0.01% | 1288 |
|
|
2018
Q4 | $242K | Buy |
+5,556
| New | +$242K | 0.01% | 1303 |
|
|
2018
Q3 | – | Sell |
-5,795
| Closed | -$281K | – | 1679 |
|
|
2018
Q2 | $281K | Buy |
+5,795
| New | +$281K | 0.01% | 1363 |
|
|
2018
Q1 | – | Sell |
-5,107
| Closed | -$217K | – | 1654 |
|
|
2017
Q4 | $217K | Buy |
+5,107
| New | +$217K | 0.01% | 1454 |
|